COVID-19 Scams Video Update, March 30, 2020

In this edition: Rise of Fake ‘Corona Cures’ Revealed in Global Counterfeit Medicine Operation, Fake ‘COVID-19 Testing Kits’ Across North America, FDA Letter: Do Not Use Chloroquine Phosphate Intended for Fish as Treatment for COVID-19, and L.A. Warns of Coronavirus Consumer Issues.

[...]

FDA Alert: Do Not Use Chloroquine Phosphate Intended for Fish as Treatment for COVID-19 in Humans

The FDA’s Center for Veterinary Medicine has recently become aware that some consumers may mistake chloroquine phosphate used to treat disease in aquarium fish for FDA-approved drugs (used to treat malaria and certain other conditions in humans) that are being studied as a COVID-19 treatment for humans. Unfortunately, we have learned that one person in the United States has died after he and his wife reportedly took chloroquine used to treat their fish in an attempt to prevent COVID-19; his wife also became very ill. We are continuing to investigate this incident.

[...]

LA City Attorney Mike Feurer Warns Consumers about Coronavirus Fraud

 According to the LA City Attorney’s Office, they have taken action to remove Internet ads that made false claims about COVID-19 prevention and treatment. The Food and Drug Administration and Federal Trade Commission have already issued a warning that there are currently no vaccines or drugs approved to treat COVID-19.

[...]

DEA Warns that Counterfeit Pills and Fentanyl Continue to Threaten Americans

Each year, the U.S. Drug Enforcement Administration pools the knowledge of law enforcement agencies around the country to produce its National Drug Threat Assessment. This year, fentanyl, counterfeit prescription pills, and the pill presses are all listed as things that will continue to endanger American lives…

[...]

HHS comments come in overwhelmingly against Canadian drug importation proposal

Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.

[...]